Companies: 10,795·Total market cap: $144.5T
Aravive, Inc.

Aravive, Inc.

ARAVNASDAQHealthcare
$0.04
$-0.01(-13.39%)
Market Cap$2949860
P/E Ratio
52W High$2.46
52W Low$0.04

Aravive, Inc. (ARAV) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · ARAV · as of Sep 30, 2025

Ownership Breakdown

Institutions 0.01%
Insiders 38.72%
Public 61.26%

1

Institutional Holders

$373

Total Inst. Value

73.56M

Shares Outstanding

freeFloat 61.28%

9,300

13F Shares Held

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

ARAV largest shareholders · institutional ownership

Q3 2025 · SEC 13F

Showing top 1 holders

HolderShares% OwnedWeightValueReportedChange

MASSMUTUAL TRUST CO FSB/ADV

pharmaceutical preparations

9.3K1.23%

1.23%

$373,000Oct 22, 2025— held

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q3 2025 vs prior quarter

Q3 2025

0

Increased

+0 shares

0

New Positions

first time holders

0

Decreased

−0 shares

0

Sold Out

fully exited

Net shares change (top 50)

+0

+0 / −0

Net new holders

+0

0 new / 0 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

ARAV insider trading · insider activity

Source: SEC Form 4

1

Buy transactions

0

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Petrini Maria Carolina

Chief Commercial Officer

Apr 10, 2023Award400,000$1.86$744.0K400.0KForm 4 ↗

McIntyre Gail Frances

CEO and President

Feb 1, 2023Award700,000$1.67$1.17M700.0KForm 4 ↗

Geller Robert B.

Chief Medical Officer

Feb 1, 2023Award400,000$1.67$668.0K400.0KForm 4 ↗

HOWARD RUDY

Chief Financial Officer

Feb 1, 2023Award400,000$1.67$668.0K400.0KForm 4 ↗

Dove Leonard Scott

Chief Operating Officer

Feb 1, 2023Award400,000$1.67$668.0K400.0KForm 4 ↗

Ho Peter Tai-Ching

director

Oct 24, 2022Award54,353$0.92$50.0K55.4KForm 4 ↗

Zhang Eric

director

Oct 24, 2022Award271,769$0.79$216.0K271.8KForm 4 ↗

Zhang Eric

director

Oct 24, 2022Award271,768$0.79$216.0K271.8KForm 4 ↗

Giaccia Amato

director

Oct 24, 2022Award271,768$0.92$250.0K1.21MForm 4 ↗

Giaccia Amato

director

Oct 24, 2022Award135,884135.9KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Aravive, Inc. (ARAV) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 38.72%, while retail and public investors account for the remaining 61.26%.

The largest institutional shareholder of Aravive, Inc. is MASSMUTUAL TRUST CO FSB/ADV, holding approximately 9,300 shares — equal to 1.23% of outstanding shares — as of September 30, 2025.

A total of 1 institutional investors currently hold ARAV stock, with a combined institutional value of approximately $373 as of the most recent 13F filing period.

Frequently asked questions

ARAV ownership

Aravive, Inc. (ARAV) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is MASSMUTUAL TRUST CO FSB/ADV with a 1.23% stake. Company insiders hold 38.72%. Data sourced from SEC Form 13F as of September 30, 2025.

who owns ARAV stockARAV ownership structureSEC Form 13F institutional holdingsARAV float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of September 30, 2025